Cheryl Cohen

Ms. Cheryl L.
Cohen is an Independent Director at Celldex Therapeutics, Inc. and a Lead Independent Director at ImmunityBio, Inc. She is on the Board of Directors at Celldex Therapeutics, Inc., ImmunityBio, Inc. and Aerpio Therapeutics LLC.
Ms. Cohen was previously employed as an Independent Director by Ignyte Acquisition Corp., an Independent Non-Executive Director by MEI Pharma, Inc., an Independent Director by NantKwest, Inc., an Independent Director by Aerpio Pharmaceuticals, Inc., an Independent Director by Vital Therapies, Inc., an Independent Director by CytRx Corp., an Independent Director by Tokai Pharmaceuticals, Inc., an Independent Director by Novus Therapeutics, Inc., a Chief Commercial Officer by Orion Acquisition Corp.
II, a President by CLC Consulting LLC, a Vice President-Strategic Commercial Group by Health Care Systems, Inc., a Vice President-Rheumatology Franchise by Centocor, Inc., a Vice President-Rheumatology Franchise by Centocor Ortho Biotech, Inc., a Principal by Solvay Pharmaceuticals, Inc., and a Vice President-Rheumatology Franchise by Johnson & Johnson.
She also served on the board at Protein Sciences Corp.
She received her undergraduate degree from Saint Joseph College.